NEWSROOM
November 19, 2020
Galderma launches Dysport® in China for treatment of glabellar lines
November 18, 2020
Dysport® is a prescription injection for temporary improvement in the look of moderate to severe glabellar lines.
November 19, 2020
Galderma Announces Top-line Results from Phase 2 Clinical Dose-Escalating Study with Azzalure® / Dysport® (abobotulinumtoxinA)
November 17, 2020
Phase 2 study on the impact of dose escalation on the duration of effect, efficacy and safety of a single dose of Dysport®
November 6, 2020
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
October 9, 2020
Phase 3 READY program of its proprietary, liquid formulation of an investigational botulinum toxin is fully enrolled.
November 5, 2020
Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year
May 12, 2020 Company to Hold GAIN Live Webinar with DREAM Investigator Tomorrow, May 13, at 7 p.m. CDT.
October 29, 2020
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
May 6, 2020
New Restylane HA Filler lasts for up to 1 year1,2 using XpresHAn Technology™.
October 29, 2020
Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China
April 22, 2020 First approval for a class III medical device for improved skin appearance in China.
October 29, 2020
Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars*
April 15, 2020
Business-building webinars to support local Aesthetic practices.
Expert injector techniques by GAIN faculty.
October 29, 2020
Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies
October 24, 2019
Ten Data Releases Will Be Presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting.
October 29, 2020
Galderma´s Azzalure and Dysport® celebrate a decade of treatment of the glabellar lines
April 4, 2019 Azzalure (marketed as Dysport outside of the EU) for the treatment of glabellar lines marks 10 year anniversary.